Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
14.82
+0.01 (0.03%)
Bozor ochiq: Aug 12, 2026, 11:23 AM EDT
14.82
0.00 (0.00%)
Oldingi bozordan keyin: Aug 11, 2026, 4:10 PM EDT
Contineum Therapeutics, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, Amerika Qo'shma Shtatlarida nevrologiya, yallig'lanish va immunologiya ko'rsatkichlari uchun turli xil kichik molekulali terapiyalarni ishlab chiqish bilan shug'ullanadi. Kompaniyaning asosiy aktivlari PIPE-791, idiopatik o'pka fibrozini va surunkali og'riqni davolash uchun yangi, miyaga kiruvchi, lizosfosfatid kislotasi 1 retseptorining (LPA1R) kichik molekulali ingibitori hisoblanadi. U shuningdek, depressiya va remitting-relapsing ko'p sklerozni davolash uchun muskarin turi 1 retseptorining yangi, kichik molekulali ingibitori bo'lgan PIPE-307ni ishlab chiqadi. Kompaniya ilgari Pipeline Therapeutics, Inc. nomi bilan tanilgan va 2023-yil noyabr oyida Contineum Therapeutics, Inc. nomini o'zgartirgan. Contineum Therapeutics, Inc. 2009-yilda ro'yxatga olingan va San-Diego, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Daniel S. Lorrain Ph.D. | Chief Science Officer |
| Dr. Timothy R. Watkins M.D., M.Sc. | Chief Medical Officer & Head of Development |
| Mr. Austin Chen Ph.D. | Senior VP & Head of Research |
| Mr. Carmine N. Stengone MBA, MS | President, CEO & Director |
| Mr. John S. Healy | General Counsel & Corporate Secretary |
| Mr. Peter T. Slover CPA | Chief Financial Officer |
| Mr. Steve E. Kunszabo | Senior Director of Investor Relations & Corporate Communications |
| Ms. Julie S. Iwashita | Senior Vice President of Clinical Operations |
| Ms. Kristina Haeckl Rac | Senior Vice President of Regulatory Affairs |
| Ms. Morgan Paulsen | Senior Manager of Accounting |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-07-30 | 8-K | ctnm-20260730.htm |
| 2026-07-30 | 10-Q | ctnm-20260630.htm |
| 2026-07-13 | 8-K | ctnm-20260713.htm |
| 2026-06-26 | 8-K | ctnm-20260626.htm |
| 2026-05-05 | 8-K | ctnm-20260505.htm |
| 2026-05-05 | 10-Q | ctnm-20260331.htm |
| 2026-04-30 | DEF 14A | ctnm-20260430.htm |
| 2026-04-30 | 8-K | ctnm-20260430.htm |
| 2026-03-05 | S-8 | a2026s-8.htm |
| 2026-03-05 | 8-K | ctnm-20260305.htm |